Viatris (VTRS) Inventory (2019 - 2026)
Viatris' (VTRS) quarterly Inventory came in at $3.9 billion in Q1 2026, down 4.14% year-on-year from $4.1 billion in Q1 2025, and down 1.81% quarter-over-quarter from $4.0 billion in Q4 2025.
Viatris (VTRS) Inventory (2019 - 2026) Analysis & Trends
Viatris' Inventory history runs 8 years deep, the most recent figure standing at $3.9 billion for Q1 2026.
- On a quarterly basis, Inventory fell 4.14% year-over-year to $3.9 billion in Q1 2026; TTM through Mar 2026 was $3.9 billion, a 4.14% decrease from a year earlier, with the FY2025 full-year figure at $4.0 billion, up 3.76% from the prior year.
- Inventory fell to $3.9 billion in Q1 2026 per VTRS's latest filing, from $4.0 billion in the prior quarter.
- Across five years, Inventory topped out at $4.3 billion in Q2 2025 and bottomed at $3.4 billion in Q3 2022.
- The 5-year median for Inventory is $3.8 billion (2024), against an average of $3.8 billion.
- Across the five-year window, Inventory decreased 23.17% in 2022 and climbed 11.24% in 2024, its largest moves.
- Year by year, Inventory stood at $3.5 billion in 2022, then fell by 1.41% to $3.5 billion in 2023, then increased by 11.08% to $3.9 billion in 2024, then gained by 3.76% to $4.0 billion in 2025, then fell by 1.81% to $3.9 billion in 2026.
- Per Business Quant, the three latest VTRS Inventory figures stand at $3.9 billion (Q1 2026), $4.0 billion (Q4 2025), and $4.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.36 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.55 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 178.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.49 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.72 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 76.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Bn |
| Dec 31, 2025 | 4.00 Bn |
| Sep 30, 2025 | 4.11 Bn |
| Jun 30, 2025 | 4.26 Bn |
| Mar 31, 2025 | 4.10 Bn |
| Dec 31, 2024 | 3.85 Bn |
| Sep 30, 2024 | 4.08 Bn |
| Jun 30, 2024 | 3.94 Bn |
| Mar 31, 2024 | 3.82 Bn |
| Dec 31, 2023 | 3.47 Bn |
| Sep 30, 2023 | 3.67 Bn |
| Jun 30, 2023 | 3.64 Bn |
| Mar 31, 2023 | 3.66 Bn |
| Dec 31, 2022 | 3.52 Bn |
| Sep 30, 2022 | 3.38 Bn |
| Jun 30, 2022 | 3.61 Bn |
| Mar 31, 2022 | 3.80 Bn |
| Dec 31, 2021 | 3.98 Bn |
| Sep 30, 2021 | 4.08 Bn |
| Jun 30, 2021 | 4.49 Bn |